Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the Immunoprotective Effects of IF-2 GTPase and SSU05-1022 as a Candidate for a Streptococcus Suis Subunit Vaccine

1 Jul 2021

Abstract excerpt

Aim: This study aims to develop a subunit vaccine with high cross-protection for Streptococcus suis. Materials & methods: Four-week-old female BALB/c mice were first immunized with a single and mixed protein. Various indicators, such as antibody titers and various cytokine levels, were further analyzed. Results: The results showed that purified recombinant proteins IF-2 and 1022 had a good protective effect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neonatal and Maternal Infections
Share to Plant Pathogenic Bacteria Studies
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34223787
DOI: 10.2217/fmb-2020-0232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the Immunoprotective Effects of IF-2 GTPase and SSU05-1022 as a Candidate for a Streptococcus Suis Subunit VaccinePMID 34223787Read ↗

Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Cross-Protection Against Streptococcus suis InfectionSemantic proximity Read ↗

A multi-epitope subunit vaccine providing broad cross-protection against diverse serotypes of Streptococcus suisSemantic proximity Read ↗

Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191Semantic proximity Read ↗

Identification and immunoprotective analysis of a Streptococcus iniae subunit vaccine candidateSemantic proximity Read ↗

Update on the development of Group A Streptococcus vaccinesSemantic proximity Read ↗

Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice.Semantic proximity Read ↗

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudySemantic proximity Read ↗

Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse modelSemantic proximity Read ↗

Protection against Group A Streptococcus by Immunization with J8–Diphtheria Toxoid: Contribution of J8‐ and Diphtheria Toxoid–Specific Antibodies to ProtectionSemantic proximity Read ↗

Application of Bacillus subtilis as a live vaccine vector: A reviewSemantic proximity Read ↗

Anthrax vaccines.Semantic proximity Read ↗

Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.